Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-039080

Director acquired 16,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Molineaux Christopher P. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-20 Exercise or conversion : show line 1 in the form +16,500 $1.41 $23,265 48,503 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-20 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −16,500 0 D
Loading xslF345X04/doc4.xml…